Jeffrey Meyehardt, MD of Harvard Medical School explains whether or not selective internal radiation therapy (SIRT) is effective in treating metastatic hepatocellular carcinoma (HCC) at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Is SIRT effective in the treatment of metastatic HCC?
